The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Enrofloxacin Market Research Report 2025
Synopsis
Enrofloxacin, also known as ciprofloxacin ethyl, is a light yellow or light yellow crystalline powder with a bitter taste and insoluble in water.
The global Enrofloxacin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enrofloxacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enrofloxacin.
Report Scope
The Enrofloxacin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enrofloxacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enrofloxacin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Vetpharma
Sunvet PharmaPrivate Limited
Dechra
Geevet Remedies
Nexgen Pharma
Nu Alter Remedies
Adelbert Vegyszerek
JPM Pharma & Chemicals Pvt. Ltd.
Sun Remedies
Merck KGaA
Segment by Type
Solution
Tablet
Pill
Others
Segment by Application
Chicken
Rabbit
Dog
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enrofloxacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enrofloxacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Enrofloxacin, also known as ciprofloxacin ethyl, is a light yellow or light yellow crystalline powder with a bitter taste and insoluble in water.
The global Enrofloxacin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Enrofloxacin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enrofloxacin.
Report Scope
The Enrofloxacin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enrofloxacin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enrofloxacin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco
Vetpharma
Sunvet PharmaPrivate Limited
Dechra
Geevet Remedies
Nexgen Pharma
Nu Alter Remedies
Adelbert Vegyszerek
JPM Pharma & Chemicals Pvt. Ltd.
Sun Remedies
Merck KGaA
Segment by Type
Solution
Tablet
Pill
Others
Segment by Application
Chicken
Rabbit
Dog
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enrofloxacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enrofloxacin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Enrofloxacin Market Overview
1.1 Product Overview and Scope of Enrofloxacin
1.2 Enrofloxacin Segment by Type
1.2.1 Global Enrofloxacin Market Value Comparison by Type (2024-2030)
1.2.2 Solution
1.2.3 Tablet
1.2.4 Pill
1.2.5 Others
1.3 Enrofloxacin Segment by Application
1.3.1 Global Enrofloxacin Market Value by Application: (2024-2030)
1.3.2 Chicken
1.3.3 Rabbit
1.3.4 Dog
1.3.5 Others
1.4 Global Enrofloxacin Market Size Estimates and Forecasts
1.4.1 Global Enrofloxacin Revenue 2019-2030
1.4.2 Global Enrofloxacin Sales 2019-2030
1.4.3 Global Enrofloxacin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enrofloxacin Market Competition by Manufacturers
2.1 Global Enrofloxacin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enrofloxacin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enrofloxacin Average Price by Manufacturers (2019-2024)
2.4 Global Enrofloxacin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enrofloxacin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enrofloxacin, Product Type & Application
2.7 Enrofloxacin Market Competitive Situation and Trends
2.7.1 Enrofloxacin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enrofloxacin Players Market Share by Revenue
2.7.3 Global Enrofloxacin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enrofloxacin Retrospective Market Scenario by Region
3.1 Global Enrofloxacin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enrofloxacin Global Enrofloxacin Sales by Region: 2019-2030
3.2.1 Global Enrofloxacin Sales by Region: 2019-2024
3.2.2 Global Enrofloxacin Sales by Region: 2025-2030
3.3 Global Enrofloxacin Global Enrofloxacin Revenue by Region: 2019-2030
3.3.1 Global Enrofloxacin Revenue by Region: 2019-2024
3.3.2 Global Enrofloxacin Revenue by Region: 2025-2030
3.4 North America Enrofloxacin Market Facts & Figures by Country
3.4.1 North America Enrofloxacin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enrofloxacin Sales by Country (2019-2030)
3.4.3 North America Enrofloxacin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enrofloxacin Market Facts & Figures by Country
3.5.1 Europe Enrofloxacin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enrofloxacin Sales by Country (2019-2030)
3.5.3 Europe Enrofloxacin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Enrofloxacin Market Facts & Figures by Country
3.6.1 Asia Pacific Enrofloxacin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enrofloxacin Sales by Country (2019-2030)
3.6.3 Asia Pacific Enrofloxacin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Enrofloxacin Market Facts & Figures by Country
3.7.1 Latin America Enrofloxacin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enrofloxacin Sales by Country (2019-2030)
3.7.3 Latin America Enrofloxacin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enrofloxacin Market Facts & Figures by Country
3.8.1 Middle East and Africa Enrofloxacin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enrofloxacin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enrofloxacin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enrofloxacin Sales by Type (2019-2030)
4.1.1 Global Enrofloxacin Sales by Type (2019-2024)
4.1.2 Global Enrofloxacin Sales by Type (2025-2030)
4.1.3 Global Enrofloxacin Sales Market Share by Type (2019-2030)
4.2 Global Enrofloxacin Revenue by Type (2019-2030)
4.2.1 Global Enrofloxacin Revenue by Type (2019-2024)
4.2.2 Global Enrofloxacin Revenue by Type (2025-2030)
4.2.3 Global Enrofloxacin Revenue Market Share by Type (2019-2030)
4.3 Global Enrofloxacin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enrofloxacin Sales by Application (2019-2030)
5.1.1 Global Enrofloxacin Sales by Application (2019-2024)
5.1.2 Global Enrofloxacin Sales by Application (2025-2030)
5.1.3 Global Enrofloxacin Sales Market Share by Application (2019-2030)
5.2 Global Enrofloxacin Revenue by Application (2019-2030)
5.2.1 Global Enrofloxacin Revenue by Application (2019-2024)
5.2.2 Global Enrofloxacin Revenue by Application (2025-2030)
5.2.3 Global Enrofloxacin Revenue Market Share by Application (2019-2030)
5.3 Global Enrofloxacin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Elanco
6.1.1 Elanco Corporation Information
6.1.2 Elanco Description and Business Overview
6.1.3 Elanco Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Elanco Enrofloxacin Product Portfolio
6.1.5 Elanco Recent Developments/Updates
6.2 Vetpharma
6.2.1 Vetpharma Corporation Information
6.2.2 Vetpharma Description and Business Overview
6.2.3 Vetpharma Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Vetpharma Enrofloxacin Product Portfolio
6.2.5 Vetpharma Recent Developments/Updates
6.3 Sunvet PharmaPrivate Limited
6.3.1 Sunvet PharmaPrivate Limited Corporation Information
6.3.2 Sunvet PharmaPrivate Limited Description and Business Overview
6.3.3 Sunvet PharmaPrivate Limited Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sunvet PharmaPrivate Limited Enrofloxacin Product Portfolio
6.3.5 Sunvet PharmaPrivate Limited Recent Developments/Updates
6.4 Dechra
6.4.1 Dechra Corporation Information
6.4.2 Dechra Description and Business Overview
6.4.3 Dechra Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Dechra Enrofloxacin Product Portfolio
6.4.5 Dechra Recent Developments/Updates
6.5 Geevet Remedies
6.5.1 Geevet Remedies Corporation Information
6.5.2 Geevet Remedies Description and Business Overview
6.5.3 Geevet Remedies Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Geevet Remedies Enrofloxacin Product Portfolio
6.5.5 Geevet Remedies Recent Developments/Updates
6.6 Nexgen Pharma
6.6.1 Nexgen Pharma Corporation Information
6.6.2 Nexgen Pharma Description and Business Overview
6.6.3 Nexgen Pharma Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nexgen Pharma Enrofloxacin Product Portfolio
6.6.5 Nexgen Pharma Recent Developments/Updates
6.7 Nu Alter Remedies
6.6.1 Nu Alter Remedies Corporation Information
6.6.2 Nu Alter Remedies Description and Business Overview
6.6.3 Nu Alter Remedies Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Nu Alter Remedies Enrofloxacin Product Portfolio
6.7.5 Nu Alter Remedies Recent Developments/Updates
6.8 Adelbert Vegyszerek
6.8.1 Adelbert Vegyszerek Corporation Information
6.8.2 Adelbert Vegyszerek Description and Business Overview
6.8.3 Adelbert Vegyszerek Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Adelbert Vegyszerek Enrofloxacin Product Portfolio
6.8.5 Adelbert Vegyszerek Recent Developments/Updates
6.9 JPM Pharma & Chemicals Pvt. Ltd.
6.9.1 JPM Pharma & Chemicals Pvt. Ltd. Corporation Information
6.9.2 JPM Pharma & Chemicals Pvt. Ltd. Description and Business Overview
6.9.3 JPM Pharma & Chemicals Pvt. Ltd. Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.9.4 JPM Pharma & Chemicals Pvt. Ltd. Enrofloxacin Product Portfolio
6.9.5 JPM Pharma & Chemicals Pvt. Ltd. Recent Developments/Updates
6.10 Sun Remedies
6.10.1 Sun Remedies Corporation Information
6.10.2 Sun Remedies Description and Business Overview
6.10.3 Sun Remedies Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sun Remedies Enrofloxacin Product Portfolio
6.10.5 Sun Remedies Recent Developments/Updates
6.11 Merck KGaA
6.11.1 Merck KGaA Corporation Information
6.11.2 Merck KGaA Enrofloxacin Description and Business Overview
6.11.3 Merck KGaA Enrofloxacin Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Merck KGaA Enrofloxacin Product Portfolio
6.11.5 Merck KGaA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enrofloxacin Industry Chain Analysis
7.2 Enrofloxacin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enrofloxacin Production Mode & Process
7.4 Enrofloxacin Sales and Marketing
7.4.1 Enrofloxacin Sales Channels
7.4.2 Enrofloxacin Distributors
7.5 Enrofloxacin Customers
8 Enrofloxacin Market Dynamics
8.1 Enrofloxacin Industry Trends
8.2 Enrofloxacin Market Drivers
8.3 Enrofloxacin Market Challenges
8.4 Enrofloxacin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Enrofloxacin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enrofloxacin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Enrofloxacin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enrofloxacin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Enrofloxacin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enrofloxacin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enrofloxacin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enrofloxacin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enrofloxacin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enrofloxacin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enrofloxacin, Product Type & Application
Table 12. Global Key Manufacturers of Enrofloxacin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enrofloxacin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enrofloxacin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enrofloxacin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enrofloxacin Sales by Region (2019-2024) & (K Units)
Table 18. Global Enrofloxacin Sales Market Share by Region (2019-2024)
Table 19. Global Enrofloxacin Sales by Region (2025-2030) & (K Units)
Table 20. Global Enrofloxacin Sales Market Share by Region (2025-2030)
Table 21. Global Enrofloxacin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enrofloxacin Revenue Market Share by Region (2019-2024)
Table 23. Global Enrofloxacin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enrofloxacin Revenue Market Share by Region (2025-2030)
Table 25. North America Enrofloxacin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enrofloxacin Sales by Country (2019-2024) & (K Units)
Table 27. North America Enrofloxacin Sales by Country (2025-2030) & (K Units)
Table 28. North America Enrofloxacin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enrofloxacin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enrofloxacin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enrofloxacin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Enrofloxacin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Enrofloxacin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enrofloxacin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enrofloxacin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enrofloxacin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Enrofloxacin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Enrofloxacin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enrofloxacin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enrofloxacin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enrofloxacin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Enrofloxacin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Enrofloxacin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enrofloxacin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Enrofloxacin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Enrofloxacin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Enrofloxacin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Enrofloxacin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Enrofloxacin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enrofloxacin Sales (K Units) by Type (2019-2024)
Table 51. Global Enrofloxacin Sales (K Units) by Type (2025-2030)
Table 52. Global Enrofloxacin Sales Market Share by Type (2019-2024)
Table 53. Global Enrofloxacin Sales Market Share by Type (2025-2030)
Table 54. Global Enrofloxacin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enrofloxacin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enrofloxacin Revenue Market Share by Type (2019-2024)
Table 57. Global Enrofloxacin Revenue Market Share by Type (2025-2030)
Table 58. Global Enrofloxacin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Enrofloxacin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Enrofloxacin Sales (K Units) by Application (2019-2024)
Table 61. Global Enrofloxacin Sales (K Units) by Application (2025-2030)
Table 62. Global Enrofloxacin Sales Market Share by Application (2019-2024)
Table 63. Global Enrofloxacin Sales Market Share by Application (2025-2030)
Table 64. Global Enrofloxacin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enrofloxacin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enrofloxacin Revenue Market Share by Application (2019-2024)
Table 67. Global Enrofloxacin Revenue Market Share by Application (2025-2030)
Table 68. Global Enrofloxacin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Enrofloxacin Price (US$/Unit) by Application (2025-2030)
Table 70. Elanco Corporation Information
Table 71. Elanco Description and Business Overview
Table 72. Elanco Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Elanco Enrofloxacin Product
Table 74. Elanco Recent Developments/Updates
Table 75. Vetpharma Corporation Information
Table 76. Vetpharma Description and Business Overview
Table 77. Vetpharma Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Vetpharma Enrofloxacin Product
Table 79. Vetpharma Recent Developments/Updates
Table 80. Sunvet PharmaPrivate Limited Corporation Information
Table 81. Sunvet PharmaPrivate Limited Description and Business Overview
Table 82. Sunvet PharmaPrivate Limited Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Sunvet PharmaPrivate Limited Enrofloxacin Product
Table 84. Sunvet PharmaPrivate Limited Recent Developments/Updates
Table 85. Dechra Corporation Information
Table 86. Dechra Description and Business Overview
Table 87. Dechra Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Dechra Enrofloxacin Product
Table 89. Dechra Recent Developments/Updates
Table 90. Geevet Remedies Corporation Information
Table 91. Geevet Remedies Description and Business Overview
Table 92. Geevet Remedies Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Geevet Remedies Enrofloxacin Product
Table 94. Geevet Remedies Recent Developments/Updates
Table 95. Nexgen Pharma Corporation Information
Table 96. Nexgen Pharma Description and Business Overview
Table 97. Nexgen Pharma Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Nexgen Pharma Enrofloxacin Product
Table 99. Nexgen Pharma Recent Developments/Updates
Table 100. Nu Alter Remedies Corporation Information
Table 101. Nu Alter Remedies Description and Business Overview
Table 102. Nu Alter Remedies Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Nu Alter Remedies Enrofloxacin Product
Table 104. Nu Alter Remedies Recent Developments/Updates
Table 105. Adelbert Vegyszerek Corporation Information
Table 106. Adelbert Vegyszerek Description and Business Overview
Table 107. Adelbert Vegyszerek Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Adelbert Vegyszerek Enrofloxacin Product
Table 109. Adelbert Vegyszerek Recent Developments/Updates
Table 110. JPM Pharma & Chemicals Pvt. Ltd. Corporation Information
Table 111. JPM Pharma & Chemicals Pvt. Ltd. Description and Business Overview
Table 112. JPM Pharma & Chemicals Pvt. Ltd. Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. JPM Pharma & Chemicals Pvt. Ltd. Enrofloxacin Product
Table 114. JPM Pharma & Chemicals Pvt. Ltd. Recent Developments/Updates
Table 115. Sun Remedies Corporation Information
Table 116. Sun Remedies Description and Business Overview
Table 117. Sun Remedies Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Sun Remedies Enrofloxacin Product
Table 119. Sun Remedies Recent Developments/Updates
Table 120. Merck KGaA Corporation Information
Table 121. Merck KGaA Description and Business Overview
Table 122. Merck KGaA Enrofloxacin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Merck KGaA Enrofloxacin Product
Table 124. Merck KGaA Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Enrofloxacin Distributors List
Table 128. Enrofloxacin Customers List
Table 129. Enrofloxacin Market Trends
Table 130. Enrofloxacin Market Drivers
Table 131. Enrofloxacin Market Challenges
Table 132. Enrofloxacin Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enrofloxacin
Figure 2. Global Enrofloxacin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enrofloxacin Market Share by Type in 2023 & 2030
Figure 4. Solution Product Picture
Figure 5. Tablet Product Picture
Figure 6. Pill Product Picture
Figure 7. Others Product Picture
Figure 8. Global Enrofloxacin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Enrofloxacin Market Share by Application in 2023 & 2030
Figure 10. Chicken
Figure 11. Rabbit
Figure 12. Dog
Figure 13. Others
Figure 14. Global Enrofloxacin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Enrofloxacin Market Size (2019-2030) & (US$ Million)
Figure 16. Global Enrofloxacin Sales (2019-2030) & (K Units)
Figure 17. Global Enrofloxacin Average Price (US$/Unit) & (2019-2030)
Figure 18. Enrofloxacin Report Years Considered
Figure 19. Enrofloxacin Sales Share by Manufacturers in 2023
Figure 20. Global Enrofloxacin Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Enrofloxacin Players: Market Share by Revenue in 2023
Figure 22. Enrofloxacin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Enrofloxacin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Enrofloxacin Sales Market Share by Country (2019-2030)
Figure 25. North America Enrofloxacin Revenue Market Share by Country (2019-2030)
Figure 26. United States Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Enrofloxacin Sales Market Share by Country (2019-2030)
Figure 29. Europe Enrofloxacin Revenue Market Share by Country (2019-2030)
Figure 30. Germany Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Netherlands Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Enrofloxacin Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Enrofloxacin Revenue Market Share by Region (2019-2030)
Figure 37. China Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Enrofloxacin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Enrofloxacin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Enrofloxacin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Enrofloxacin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Enrofloxacin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Enrofloxacin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Enrofloxacin by Type (2019-2030)
Figure 56. Global Enrofloxacin Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Enrofloxacin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Enrofloxacin by Application (2019-2030)
Figure 59. Global Enrofloxacin Price (US$/Unit) by Application (2019-2030)
Figure 60. Enrofloxacin Value Chain
Figure 61. Enrofloxacin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
